Emerging evidence indicates that FOSL1 is upregulated in GBM and facilitates tumor progression by modulating several oncogenic pathways, including MAPK, PI3K/Akt, TGF‐β, and Wnt/β‐catenin [14, 15, 16]. This evidence concerns the gene FOSL1 and glioblastoma.